Steward Partners Investment Advisory’s Repare Therapeutics RPTX Stock Holding History

Steward Partners Investment Advisory’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11	Closed	-$29	–	4542
2025 Q4	$29	Hold	11	–	–	﹤0.01%	4264
2025 Q3	$19	Hold	11	–	–	﹤0.01%	4235
2025 Q2	$15	Hold	11	–	–	﹤0.01%	4096
2025 Q1	$11	Buy	+11	New	+$13	﹤0.01%	4000

Steward Partners Investment Advisory's RPTX Position: Q1 2026 in Review

Steward Partners Investment Advisory sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 11 shares — an estimated $29 sold.

Steward Partners Investment Advisory first reported a position in RPTX in Q1 2025 and held it in 4 quarters. The position peaked at $29 in Q4 2025. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

Steward Partners Investment Advisory reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
Steward Partners Investment Advisory sold 11 Repare Therapeutics shares in Q1 2026, an estimated $29.
Steward Partners Investment Advisory first reported a position in Repare Therapeutics in Q1 2025 and held it in 4 quarters.
Steward Partners Investment Advisory's Repare Therapeutics position peaked at $29 in Q4 2025.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.